PS II unveiled

Credit: Courtesy of Imperial College London" /> Credit: Courtesy of Imperial College London The photosynthetic enzyme Photosystem II (PSII) generates all of Earth?s atmospheric oxygen through a thermodynamically unfavorable reaction, splitting water into hydrogen and oxygen using solar energy. ?It?s been the Holy Grail of photosynthesis research ? to obtain structural information about the catalytic center where this very remarkable reaction occurs,? says biochemist James Barber o

Written byAileen Constans
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The photosynthetic enzyme Photosystem II (PSII) generates all of Earth?s atmospheric oxygen through a thermodynamically unfavorable reaction, splitting water into hydrogen and oxygen using solar energy. ?It?s been the Holy Grail of photosynthesis research ? to obtain structural information about the catalytic center where this very remarkable reaction occurs,? says biochemist James Barber of Imperial College London.

Barber and colleagues? 3.5 angstrom structure of a cyanobacterial PSII represented the highest resolution to date obtained for the enzyme, and revealed the oxygen-evolving center (OEC) as a cubane-like structure consisting of three manganese ions and one calcium ion, surrounded by amino acids that either act as ligands to the metal ions or make up the cavity in which the water-splitting reaction occurs.1 A fourth manganese ion linked to the cube facilitates the reaction, Barber says.

Beyond overcoming the significant challenges of crystallizing a membrane-bound protein, the research has practical implications. ?It?s allowed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies